Add to ORKGMortality in infarct-related cardiogenic shock (CS) remains high, reaching 40–50%. In refractory CS, active mechanical circulatory support devices including veno-arterial extracorporeal membrane oxygenation (VA-ECMO) are rapidly evolving. However, supporting evidence of VA-ECMO therapy in infarct-related CS is low. The current review aims to give an overview on the basics of VA-ECMO therapy, current evidence, ongoing trials, patient selection and potential complications
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
Mortality in infarct-related cardiogenic shock (CS) remains high, reaching 40–50%. In refractory CS,...
Background. Cardiogenic shock is associated with high mortality, despite new strategies for reperfus...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock accounts for ~100,000 annual hospital admissions in the United States. Despite imp...
Refractory Cardiogenic shock (CS) complicates 5–7% of cases of ST-elevation myocardial infarction (S...
Background Use of veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) has become increasing...
Background In acute myocardial infarction complicated by cardiogenic shock the use of mechanical cir...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
Mortality in infarct-related cardiogenic shock (CS) remains high, reaching 40–50%. In refractory CS,...
Background. Cardiogenic shock is associated with high mortality, despite new strategies for reperfus...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient systemic p...
Cardiogenic shock accounts for ~100,000 annual hospital admissions in the United States. Despite imp...
Refractory Cardiogenic shock (CS) complicates 5–7% of cases of ST-elevation myocardial infarction (S...
Background Use of veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) has become increasing...
Background In acute myocardial infarction complicated by cardiogenic shock the use of mechanical cir...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...
International audienceThe use of Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO) as a sa...